[Skip to Content]
[Skip to Content Landing]
November 2003

Reconstruction After Orbital Exenteration

Author Affiliations

Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2003

Arch Ophthalmol. 2003;121(11):1662. doi:10.1001/archopht.121.11.1662-a

In a recent article describing a useful well-known technique for reconstruction after orbital exenteration, Uusitalo and coworkers1 described a patient who underwent orbital exenteration for primary rhabdomyosarcoma. We find this surprising because the Intergroup Rhabdomyosarcoma Study found a 10-year overall survival rate of 87% with use of chemotherapy with or without adjunctive radiation.2 Our service (Oculoplastic and Orbital Surgery, Massachusetts Eye and Ear Infirmary, Boston, Mass) refers biopsy-proved cases of orbital rhabdomyosarcoma to pediatric oncology, where the present protocol includes 1 year of intravenous vincristine sulfate and dactinomycin with or without radiation. It would be interesting to know what specific characteristics of this case indicated exenteration.

First Page Preview View Large
First page PDF preview
First page PDF preview